Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-01-17 1:20 pm Sale | 2022-12-31 | 13G | Werewolf Therapeutics, Inc. HOWL | PFM Health Sciences LP | 1,293,293 4.200% | -223,733 (-14.75%) | Filing History |
| 2023-01-10 5:11 pm Purchase | 2023-01-06 | 13D | 89bio, Inc. ETNB | RA Capital Management, L.P. | 6,159,054 17.960% | 1,854,607 (+43.09%) | Filing History |
| 2022-08-12 4:32 pm Purchase | 2009-02-28 | 13D | 89bio, Inc. ETNB | RA Capital Management, L.P. | 4,304,447 14.570% | 12,566 (+0.29%) | Filing History |
| 2022-05-02 4:02 pm Purchase | 2022-04-21 | 13G | Werewolf Therapeutics, Inc. HOWL | PFM Health Sciences LP | 1,517,026 5.500% | 1,517,026 (New Position) | Filing History |
| 2022-02-11 4:11 pm Sale | 2021-12-31 | 13G | Werewolf Therapeutics, Inc. HOWL | Deerfield Mgmt, L.P. | 958,125 3.470% | -1,594,662 (-62.47%) | Filing History |
| 2021-06-16 4:59 pm Purchase | 2009-02-28 | 13D | 89bio, Inc. ETNB | RA Capital Management, L.P. | 4,291,881 15.600% | 4,291,881 (New Position) | Filing History |
| 2021-05-14 5:18 pm Purchase | 2021-05-04 | 13D | Werewolf Therapeutics, Inc. HOWL | MPM BioVentures 2014, L.P. | 6,731,087 24.400% | 6,731,087 (New Position) | Filing History |
| 2021-05-14 4:42 pm Purchase | 2021-05-04 | 13G | Werewolf Therapeutics, Inc. HOWL | Longwood Fund III GP LLC | 1,677,082 6.100% | 1,677,082 (New Position) | Filing History |
| 2021-05-13 4:30 pm Purchase | 2021-05-04 | 13D | Werewolf Therapeutics, Inc. HOWL | Taiho Ventures LLC | 2,068,909 7.510% | 2,068,909 (New Position) | Filing History |
| 2021-05-10 11:21 am Purchase | 2021-04-29 | 13D | Werewolf Therapeutics, Inc. HOWL | Moshe Arkin | 2,046,634 7.400% | 2,046,634 (New Position) | Filing History |
| 2021-05-06 4:33 pm Purchase | 2021-05-04 | 13D | Werewolf Therapeutics, Inc. HOWL | RA Capital Management, L.P. | 3,968,583 14.400% | 3,968,583 (New Position) | Filing History |
| 2021-05-04 12:33 pm Purchase | 2021-05-04 | 13G | Werewolf Therapeutics, Inc. HOWL | Deerfield Mgmt, L.P. | 2,552,787 9.270% | 2,552,787 (New Position) | Filing History |